Prosecution Insights
Last updated: April 19, 2026

Shihuida Pharmaceutical Group (Jilin) Co. Ltd.

2 pending office actions

Portfolio Summary

2
Total Pending OAs
0
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18546077 USE OF CLOSTRIDIUM GHONII SPORE COMBINED WITH PEMBROLIZUMAB HAUK TEODORO, PRICILA NMN 1645 Non-Final OA Aug 10, 2023
17919043 PREPARATION SPECIFICALLY BOUND WITH CD137 AND USE THEREOF SHUPE, ELIZABETH A 1643 Non-Final OA Oct 14, 2022

Managing Shihuida Pharmaceutical Group (Jilin) Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month